A detailed history of Aigen Investment Management, LP transactions in Insmed Inc stock. As of the latest transaction made, Aigen Investment Management, LP holds 11,936 shares of INSM stock, worth $942,227. This represents 0.15% of its overall portfolio holdings.

Number of Shares
11,936
Previous 4,069 193.34%
Holding current value
$942,227
Previous $297,000 177.44%
% of portfolio
0.15%
Previous 0.06%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

BUY
$66.29 - $76.63 $521,503 - $602,848
7,867 Added 193.34%
11,936 $824,000
Q3 2024

Nov 05, 2024

BUY
$62.0 - $79.01 $252,278 - $321,491
4,069 New
4,069 $297,000
Q4 2022

Feb 10, 2023

BUY
$16.98 - $23.15 $307,796 - $419,640
18,127 New
18,127 $362,000
Q2 2022

Aug 02, 2022

SELL
$17.07 - $25.71 $310,981 - $468,384
-18,218 Closed
0 $0
Q1 2022

May 05, 2022

BUY
$20.42 - $28.13 $372,011 - $512,472
18,218 New
18,218 $428,000
Q1 2021

May 11, 2021

SELL
$32.28 - $44.3 $238,904 - $327,864
-7,401 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$31.45 - $40.54 $108,785 - $140,227
-3,459 Reduced 31.85%
7,401 $246,000
Q3 2020

Nov 06, 2020

BUY
$26.0 - $34.5 $282,360 - $374,670
10,860 New
10,860 $349,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.7B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.